Instructor in Medicine
Dr. Chandra specializes in Mycobacterium tuberculosis pathogenesis, with a special focus on immunometabolism. In recent work, she characterized a novel relationship between macrophage fatty acid metabolism and antimycobacterial immunity.
Professor, Departments of Medicine, Molecular Microbiology
Dr. Fleckenstein’s lab focuses on the identification and molecular characterization of novel ETEC virulence factors that could serve as targets for vaccine development. Studies in the lab use a variety of molecular techniques and in vitro and in vivo models to elucidate the role of these novel virulence factors in several key steps essential in the pathogenesis of these organisms: bacterial adhesion, intestinal colonization, and finally toxin delivery.
Professor of Medicine and Molecular Microbiology
Dr. Henderson specializes in infection pathogenesis, with a special focus on urinary tract infections and identifying how special bacterial adaptations increase pathogenic potential in patients.
Associate Professor of Medicine
Dr. Miller manages core operations, technical & scientific consultations , 2-photon imaging. His interests are in vivo imaging approaches to study cellular immunity, in particular cellular mechanisms of antigen presentation and leukocyte trafficking during infection and inflammation.
Theodore and Bertha Bryan Professor, Departments of Medicine and Molecular Microbiology; Co-director, Infectious Diseases Division
Dr. Philips is principal investigator of an NIH-funded lab that studies how Mycobacterium tuberculosis evades the host immune response.